Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

BACKGROUND: Combinations of trastuzumab with either docetaxel or vinorelbine are considered valuable treatment options for HER2-positive metastatic breast cancer patients. We performed a retrospective comparison of the clinical outcomes associated with either one of these combinations. METHODS: From...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Redana, Stefania, Donadio, Michela, Nolè, Franco, Jacomuzzi, Maria Elena, Beano, Alessandra, Martinello, Rossella, Sapino, Anna, Viale, Giuseppe, Aglietta, Massimo, Montemurro, Filippo
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2010
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2835645/
https://ncbi.nlm.nih.gov/pubmed/20122160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-28
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים